162 related articles for article (PubMed ID: 17662495)
21. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
[TBL] [Abstract][Full Text] [Related]
22. [Use of brain natriuretic peptide (BNP) in the diagnosis and treatment of heart failure].
Martin-Du Pan RC; Ricou F
Rev Med Suisse Romande; 2003 Feb; 123(2):125-8. PubMed ID: 15095695
[TBL] [Abstract][Full Text] [Related]
23. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure.
Gackowski A; Isnard R; Golmard JL; Pousset F; Carayon A; Montalescot G; Hulot JS; Thomas D; Piwowarska W; Komajda M
Eur Heart J; 2004 Oct; 25(20):1788-96. PubMed ID: 15474693
[TBL] [Abstract][Full Text] [Related]
24. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
Chung T; Sindone A; Foo F; Dwyer A; Paoloni R; Janu MR; Wong H; Hall J; Freedman SB
Am Heart J; 2006 Nov; 152(5):949-55. PubMed ID: 17070166
[TBL] [Abstract][Full Text] [Related]
25. Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure.
Feola M; Rosso GL; Peano M; Agostini M; Aspromonte N; Carena G; Salvatico L; Valle R
Arch Med Res; 2007 Feb; 38(2):234-9. PubMed ID: 17227734
[TBL] [Abstract][Full Text] [Related]
26. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.
Gerber IL; Stewart RA; Legget ME; West TM; French RL; Sutton TM; Yandle TG; French JK; Richards AM; White HD
Circulation; 2003 Apr; 107(14):1884-90. PubMed ID: 12668523
[TBL] [Abstract][Full Text] [Related]
27. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
[TBL] [Abstract][Full Text] [Related]
28. [Usefulness of brain natriuretic peptide to evaluate patients with heart failure treated with cardiac resynchronization].
Hernández Madrid A; Miguelañez Díaz M; Escobar Cervantes C; Blanco Tirados B; Marín I; Bernal E; Zamora J; Cordova González FJ; Alfonso Pérez M; Limón L; González Rebollo JM; Moya Mur JL; Moro C
Rev Esp Cardiol; 2004 Apr; 57(4):299-305. PubMed ID: 15104983
[TBL] [Abstract][Full Text] [Related]
29. Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?
Schaufelberger M; Bergh CH; Caidahl K; Eggertsen R; Furenäs E; Lindstedt G; Nilsson T; Stefferud K; Swedberg K
Scand J Prim Health Care; 2004 Sep; 22(3):187-90. PubMed ID: 15370797
[TBL] [Abstract][Full Text] [Related]
30. Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
Wasywich CA; Webster MW; Richards AM; Stewart RA
Am J Cardiol; 2006 Apr; 97(7):1068-72. PubMed ID: 16563918
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery.
Nessmith MG; Fukuta H; Brucks S; Little WC
Am J Cardiol; 2005 Nov; 96(10):1445-8. PubMed ID: 16275196
[TBL] [Abstract][Full Text] [Related]
32. Cardiac troponin levels in heart failure.
Potluri S; Ventura HO; Mulumudi M; Mehra MR
Cardiol Rev; 2004; 12(1):21-5. PubMed ID: 14667259
[TBL] [Abstract][Full Text] [Related]
33. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Mundigler G; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H
Circulation; 2004 May; 109(19):2302-8. PubMed ID: 15117847
[TBL] [Abstract][Full Text] [Related]
34. The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure.
Krüger S; Graf J; Merx MW; Stickel T; Kunz D; Koch KC; Hanrath P; Janssens U
Eur J Intern Med; 2006 Mar; 17(2):96-101. PubMed ID: 16490685
[TBL] [Abstract][Full Text] [Related]
35. [Biomarkers for the evaluation of valvular aortic stenosis].
Weber M; Hamm C
Herz; 2006 Oct; 31(7):658-63. PubMed ID: 17072779
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of heart-type fatty acid-binding protein for left ventricular remodelling and clinical outcome of hypertensive patients with mild-to-moderate aortic valve diseases.
Iida M; Yamazaki M; Honjo H; Kodama I; Kamiya K
J Hum Hypertens; 2007 Jul; 21(7):551-7. PubMed ID: 17392813
[TBL] [Abstract][Full Text] [Related]
37. The role of BNP testing in heart failure.
Doust J; Lehman R; Glasziou P
Am Fam Physician; 2006 Dec; 74(11):1893-8. PubMed ID: 17168346
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
Karmpaliotis D; Kirtane AJ; Ruisi CP; Polonsky T; Malhotra A; Talmor D; Kosmidou I; Jarolim P; de Lemos JA; Sabatine MS; Gibson CM; Morrow D
Chest; 2007 Apr; 131(4):964-71. PubMed ID: 17426196
[TBL] [Abstract][Full Text] [Related]
39. Brain natriuretic peptide in diagnosis and treatment of heart failure.
Bhatia V; Nayyar P; Dhindsa S
J Postgrad Med; 2003; 49(2):182-5. PubMed ID: 12867703
[TBL] [Abstract][Full Text] [Related]
40. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
